Neuronetics Inc. (NASDAQ: STIM) Stock Information | RedChip

Neuronetics Inc. (NASDAQ: STIM) Listen to this Section


$1.12
+0.1550 ( +16.06% ) 919.6K

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Market Data


Open


$1.12

Previous close


$0.97

Volume


919.6K

Market cap


$33.93M

Day range


$0.94 - $1.20

52 week range


$0.66 - $5.07

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 12 Nov 07, 2023
8-k 8K-related 14 Nov 07, 2023
10-q Quarterly Reports 85 Nov 07, 2023
4 Insider transactions 1 Oct 10, 2023
4 Insider transactions 1 Oct 10, 2023
8-k 8K-related 14 Oct 03, 2023
4/a Other 1 Sep 20, 2023
4 Insider transactions 1 Aug 11, 2023
8-k 8K-related 14 Aug 08, 2023
10-q Quarterly Reports 83 Aug 08, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.